Hogi Medical is set to be delisted following a tender offer from the Carlyle Group, aimed at enhancing its operational efficiency and market value.
Target Information
Hogi Medical, founded in 1955 and listed on the Tokyo Prime Market, specializes in products and services necessary for surgical procedures. Their flagship offerings include the "Premium Kit," which delivers essential consumables, and the "Opera Master," a management tool aimed at optimizing surgical operations. The company recognizes that the evolving landscape of healthcare organizations requires continuous enhancement of its product portfolio, a strengthening of sales tactics, and an emphasis on expanding international operations.
Industry Overview in Japan
Japan's medical device and healthcare technology sector has been undergoing significant changes, driven by a pressing need for innovation and cost-efficiency. With an aging population, the demand for effective medical solutions has never been higher. Healthcare institutions are increasingly focusing on minimizing operational costs while improving patient outcomes.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
This shift has led to a burgeoning market for companies that can provide innovative products to help ease the burdens on healthcare professionals, such as docto
Similar Deals
Omron Healthcare → Matsuya R&D
2025
Advantage Partners (AP) and LYFE Capital Investment Management Ltd. → Nihon Chouzai Co., Ltd.
2025
Tokyo University Co-Creation Platform Development Co., Ltd. → Heartseed Inc.
2024
San Holdings → Kizuna Holdings
2023
Carlyle Group
invested in
HOGY Medical
in 2025
in a Public-to-Private (P2P) deal
Disclosed details
Transaction Size: $130M